Yazen Health AB

Name: Longitudinal real-world obesity/GLP-1 treatment cohort from a digital weight-management program: per-patient prescription and refill sequences for GLP-1 receptor agonists, prospectively recorded discontinuation reason codes, paired lifestyle-intervention exposure (coaching and behavioral program engagement), weight trajectory, and physician-guided treatment decisions — published as a Swedish cohort of 25,824 patients
Creator: Yazen Health AB

YAZEN HEALTH ABManage supplier listing

Longitudinal real-world obesity/GLP-1 treatment cohort from a digital weight-management program: per-patient prescription and refill sequences for GLP-1 receptor agonists, prospectively recorded discontinuation reason codes, paired lifestyle-intervention exposure (coaching and behavioral program engagement), weight trajectory, and physician-guided treatment decisions — published as a Swedish cohort of 25,824 patients

Open buyer room →

Sample

Brickroad customers

Sample this dataset before you buy it.

Your sourcing agent asks Yazen Health AB and files the sample in your catalog — private to you.

Start 7-day trialNothing is charged until the trial ends.

Coverage

Universe, instruments and categories.

Industry: Health Care TechnologyPharmaceuticals
Instruments: equities
Categories: AlternativeFundamental
Regions: OtherUS
Sample tickers: NVOLLYASNAMGNAZNELVCVSUNH

Dataset card

Type: not stated
Format: Tabular longitudinal patient records (episode/visit, prescription and dispense dates, days-supply-derived adherence intervals, discontinuation event with reason category, weight measurements) plus app-interaction and program-engagement event data from the digital coaching layer
Volume: Stated cohort of 25,824 patients observed to 24 months; estimate several million longitudinal records across visits, prescriptions, refills, weight measurements and program-engagement events (each patient contributing dozens to hundreds of time-stamped rows over a multi-year episode)
Users: ~26K+ patients treated in the published Swedish cohort alone (n=25,824 stated in the company's own analysis); total program population higher across Sweden and UK operations
History: 5 years
Update frequency: not stated
Growth: Active — the company is running ongoing analyses and publishing new GLP-1 outcome work, operates in Sweden and the UK (multi-market expansion), and carries ~290 staff with $32.4M of financing including debt, indicating an operating scale-up
Launched: not stated
Delivery: not stated
Entity mapping: not stated
Sample: not stated
Point-in-time: not stated
Licence: not stated

supplier index read from their site

Yazen Health AB has not added their own details yet. Not yet on file:

Dataset
Data dictionary
Coverage
Provenance
Rights & data handling